July 6, 2021
The Ministry of Health, Labor and Welfare (MHLW) has granted orphan drug designation to PTC Therapeutics International’s PTC743 for the treatment of Leigh syndrome, a mitochondrial disease. PTC743 was previously being developed by Sumitomo Dainippon Pharma under the code name...read more